Concord, CA, United States of America

Martin J Fennell

This inventor holds 71 USPTO granted patents and 47 published patent applications, plus 8 CIPO patents and 15 EPO patents, primarily in Analyte Monitoring Systems (CPC class A61B). Top assignee: Abbott Diabetes Care Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin J Fennell. Retrieved from https://idiyas.com/inventor/martin-j-fennell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 71 

% Patents Active = 84.5

 

 

Average Co-Inventor Count = 2.5

ph-index = 19

Forward Citations = 1,575(Granted Patents)

Forward Citations (Not Self Cited) = 1,210(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Analyte Monitoring
Medical Devices
Power Management
Temperature Compensation
Signal Processing
Health Management
Dosage Optimization
Sensor Devices
RF Commands
Dynamic Amplification
71 patents (USPTO):Explore Patents

Title: The Innovations of Martin J. Fennell: A Pioneer in RF Command Handling and Medication Dosage Optimization

Introduction

Martin J. Fennell, based in Concord, CA, is an accomplished inventor with an impressive portfolio of 61 patents. His work focuses on significant advancements in both radio frequency (RF) command handling and optimizing medication administration, showcasing a commitment to innovation that positively impacts healthcare technologies.

Latest Patents

Fennell's recent patents include groundbreaking systems and methods for revising or supplementing ROM-based RF commands. These innovations provide enhanced capabilities for revising RF command handling software housed in read-only memory (ROM), utilizing a lookup data structure stored within writable non-volatile memory.

Another noteworthy patent involves optimizing medication dosage based on analyte sensor data. This invention outlines methods and systems to determine the appropriate administration of medication, allowing for either whole or fractional doses based on real-time analyte level assessments and their rates of change. This innovative approach ensures greater precision in medication delivery, improving patient outcomes.

Career Highlights

Fennell is currently affiliated with Abbott Diabetes Care Inc. Here, he leverages his expertise to develop cutting-edge solutions that address real-world medical challenges. His contributions are pivotal in the realm of diabetes management and medical technology.

Collaborations

Throughout his career, Fennell has collaborated with talented colleagues, including Mark Kent Sloan and Lei He. Their combined efforts represent a synergy of ideas and expertise, enhancing the innovative landscape at Abbott and driving forward-thinking developments in healthcare technology.

Conclusion

Martin J. Fennell stands out as a prominent figure in the realm of innovation, with a vast range of patents that facilitate advancements in RF command handling and medication optimization. His dedication to improving healthcare solutions through inventive technologies marks him as an influential inventor in his field, with lasting impacts on both patient care and medical device efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…